MAPT and Alzheimer disease: AD is defined by distinct alterations in the brain, such as the accumulation of amyloid-beta (Aβ) protein and neurofibrillary tangles (NFTs) of phosphorylated tau (p-tau) proteins, leading to progressive neuronal loss.